Skip to main content
Reckitt Benckiser Group PLC logo

Reckitt Benckiser Group PLC — Investor Relations & Filings

Ticker · RKT ISIN · GB00B24CGK77 LEI · 5493003JFSMOJG48V108 IL Manufacturing
Open in API
Filings indexed 1,842 across all filing types
Latest filing 2017-02-10 Earnings Release
Country GB United Kingdom
Listing IL RKT

About Reckitt Benckiser Group PLC

https://www.reckitt.com/

Reckitt Benckiser Group PLC is a global manufacturer of consumer products in the health, hygiene, and nutrition sectors. The company's mission is to protect, heal, and nurture in the pursuit of a cleaner, healthier world. It operates a portfolio of trusted brands, many of which hold market-leading positions in their categories. Key brands include Lysol, Dettol, Durex, Mucinex, Nurofen, Strepsils, Gaviscon, Finish, and Vanish. Leveraging scientific expertise and consumer insights, the company develops and distributes products designed to improve the daily lives of consumers worldwide, with over 30 million of its products sold daily.

Recent filings

Filing Released Lang Actions
Full Year Results 2016
Earnings Release Classification · 98% confidence The document is dated February 10, 2017, and presents '2016 - SOLID GROWTH, EXCELLENT MARGIN EXPANSION' with detailed tables showing 'Results at a glance' for Q4 and FY 2016, including Net Revenue, Operating Profit, and EPS figures. It includes CEO commentary and extensive discussion of financial performance metrics (LFL growth, margins, exceptional items, dividend recommendation). This structure is characteristic of an Earnings Release (ER) or a comprehensive Interim/Annual Report. Since it covers the full fiscal year (FY 2016) and provides detailed financial results, it strongly suggests an Annual Report (10-K) or a very detailed Earnings Release. However, the presence of the RNS Number (5561W) and the introductory format strongly suggest this is the initial public announcement of the full-year results, which aligns best with an Earnings Release (ER), even though it contains substantial detail. Given the length and depth, it could also be considered part of the Annual Report process, but the RNS header points to an immediate public disclosure. Comparing ER vs 10-K: A 10-K is the official SEC filing. This document is filed via RNS, which is common for UK-listed companies announcing results. The content is the core financial summary and commentary. Since it is a comprehensive summary of the full year's results, it fits the definition of an Earnings Release (ER) which is the initial announcement of periodical financial results (key highlights only, though this one is quite detailed). If it were the full 10-K, it would typically reference the SEC filing explicitly. Given the RNS format and the focus on summarizing the year's performance immediately, ER is the most appropriate classification for this type of regulatory announcement. Revisiting definitions: ER is 'Initial announcement of quarterly/periodical financial results (key highlights only)'. 10-K is 'Official yearly report covering company activity and full financial performance.' This document is very long (83k chars) and detailed, suggesting it might be the full Annual Report content released via RNS, or a very comprehensive ER. Given the explicit mention of 'Full Year 2016' results and the depth, it leans towards the comprehensive report itself, but the RNS wrapper suggests an immediate release. In many contexts, the RNS announcement containing the full results summary is classified as the Earnings Release (ER) or sometimes Regulatory Filing (RNS) if the actual 10-K is separate. Since it contains the core financial tables and CEO review for the full year, ER is the best fit among the immediate result categories. FY 2016
2017-02-10 English
Statement regarding Mead Johnson
M&A Activity Classification · 99% confidence The document is a short announcement (1537 characters) identified by an 'RNS Number' and originating from the 'London Stock Exchange' news service. It explicitly addresses 'recent press speculation regarding a possible transaction involving Mead Johnson Nutrition Company' and confirms 'advanced negotiations to acquire' the company for a specific cash value ($90 per share, $16.7 billion total). This clearly indicates an announcement related to a potential merger or takeover bid. Based on the definitions, this aligns perfectly with the M&A Activity category (TAR). It is not a full report, but a specific transaction announcement.
2017-02-02 English
MJ Annual Financial Statements 2016
Annual Report Classification · 100% confidence The document contains a formal 'Report of Independent Registered Public Accounting Firm' followed by comprehensive consolidated financial statements (Balance Sheets, Statements of Earnings, Comprehensive Income, Equity, and Cash Flows) and detailed notes to the financial statements for the fiscal years 2014, 2015, and 2016. This structure is characteristic of the financial section of a 10-K annual report. Since it provides the full audited financial results for the year, it is classified as a 10-K. FY 2016
2016-12-31 English
2016 Annual Report and Financial Statements
Annual Report Classification · 100% confidence The document is the 'Reckitt Benckiser Group plc (RB) Annual Report and Financial Statements 2016'. It contains comprehensive sections including a Strategic Report, Governance, Financial Statements, Chairman's Statement, and detailed financial performance metrics. It is clearly the full annual report for the fiscal year 2016, not an announcement or a summary. FY 2016
2016-12-31 English
Transaction in Own Shares
Transaction in Own Shares Classification · 99% confidence The document is an RNS announcement from Reckitt Benckiser Group PLC dated 05 December 2016. The title is "TRANSACTION IN OWN SECURITIES" and the content details the purchase of Ordinary Shares on the London Stock Exchange, including the date, number of shares, and price ranges. This activity directly corresponds to the definition of a company buying back or selling its own shares. Therefore, the appropriate filing type is 'Transaction in Own Shares' (POS).
2016-12-05 English
Director/PDMR Shareholding
Remuneration Information Classification · 99% confidence The document is identified by the RNS Number (8615Q) and the title 'DIRECTOR/PDMR SHAREHOLDINGS'. It details the grant of share options and conditional awards to Directors and Persons Discharging Managerial Responsibilities (PDMRs) under the Long Term Incentive Plan (LTIP). This type of filing, reporting insider transactions (specifically executive share awards/grants), directly corresponds to the definition of Director's Dealing (DIRS). Although it involves share transactions, the focus is on executive/director dealings rather than general share repurchases (POS) or capital changes (SHA).
2016-12-02 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.